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We recently reported a murine model for the study of specific transplantation 
tolerance  induced  by  total  body  irradiation  and  reconstitution  with  T  cell 
depleted  syngeneic  (B10)  plus  T  cell-depleted  allogeneic (B10.D2/nSn)  bone 
marrow  (B10  +  B10.D2  ~  B10)  (1).  Such  recipients  repopulated  as  mixed 
lymphopoietic chimeras and were specifically tolerant to the B10.D2 allogeneic 
donor in vivo and in vitro, yet retained immunocompetence at a level similar to 
that of syngeneically reconstituted (B10 ~  B10) recipients (2).  T  cell depletion 
of the syngeneic component of the mixed allogeneic bone marrow inoculum was 
essential  for  engraftment  of the  allogeneic  donor  and  for  induction  of this 
specific transplantation tolerance. If the syngeneic donor marrow was not T  cell- 
depleted, animals repopulated as fully syngeneic chimeras were not tolerant to 
BI0.D2  allogeneic  donor  skin  grafts,  and  were  reactive  in  vitro  to  B10.D2 
lymphoid elements in MLR and cell mediated lympholysis (CML) assays (3). 
To the extent that failure ofallogeneic engraftment in this model may correlate 
with  failure  of allogeneic  bone  marrow  engraftment  in  general,  these  results 
provide a means for identifying the critical syngeneic cell phenotype responsible 
for the  alloresistance  to engraftment  observed.  We report  here  the results  of 
selective depletions of various T  cell subsets (L3T4  +, Lyt-2  ÷, Thy-1 +) from the 
syngeneic component of the mixed bone marrow inoculum by the use of mAbs 
plus complement. Our results indicate that the critical syngeneic cell phenotype 
that  prevents engraftment  of allogeneic donor bone marrow and  tolerance  to 
the donor alloantigens in mixed allogeneic reconstitution resides among the Lyt- 
2 + subset of T  lymphocytes. 
Materials and Methods 
Animals.  4-6-wk-old mice of strains C57BL/10Sn (B10), B10.D2/nSn (B10.D2), and 
B 10.BR (The Jackson Laboratory, Bar Harbor, ME) were used. 
Preparation of Chimeras.  Preparation of mixed allogeneic chimeras (B10 + B10.D2 
B10) was carried out as previously described (1, 2). T  cell depletions of bone marrow 
were performed  using  rabbit anti-mouse  brain  (RAMB) plus  guinea pig complement 
(GPC) as previously described, as well as using mAbs GK1.5 (anti-L3T4a),  83-12-5 (anti- 
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Lyt-2.2),  and  20-10-5  (anti-Thy-1)  (4), plus  low-cytotoxicity  rabbit  complement.  The 
monoclonal  mouse anti-Lyt-2.2  antibody (83-12-5) was generated from the fusion of the 
spleen from a C3H/HeJ mouse immunized  with an Lyt-2.2 bearing cytotoxic T cell clone, 
BM 10-5.6. The monoctonal rat anti-L3T4 antibody (GK1.5) was a gift of Dr. Frank Fitch 
(University of Chicago, Chicago, IL). Adequacy of cellular depletions was confirmed using 
flow microfluorometry (FMF). 
Characterization of Chimeras by FMF.  Recipients  were characterized for engraftment 
with syngeneic and/or allogeneic  donor l~mphoid elements using FMF to determine the 
percentage of PBL bearing H-2  b and H-2  surface markers (1, 2). Arbitrary levels on log 
scale were selected based on the inflection  point where staining  of the control negative 
population was minimized while retaining staining of maximal numbers of positive cells. 
Skin Grafting.  Skin  grafting  was performed  6  wk  postreconstitution  as  previously 
described (1,  2).  Graft survivals were calculated  by the life-table  method (5), and the 
Median Survival Time (MST) derived from the time point at which 50% of grafts were 
surviving. 
Assays of Cellular Immunity.  Mixed lymphocyte culture proliferative assays and CML 
assays were performed as previously described (2). 
Results 
Cell Surface Phenotype of  Syngeneic Bone Marrow Cell Responsible  for Alloresistance 
to Engraftment  in Mixed Allogeneic Reconstitution.  Chimeras  were prepared ac- 
cording to the following five protocols and were characterized for engraftment 
of allogeneic donor bone marrow cells: Group  1, 5  x  10  6 Lyt-2÷-depleted B10 
bone marrow cells +  15 x  106 RAMB B10.D2; Group 2, 5 X 106 L3T4+-depleted 
B10 bone marrow cells +  15 x  106 RAMB B10.D2; Group 3, 5  X  108 Thy-1 ÷- 
depleted B10 bone marrow cells +  15 x  108 RAMB B10.D2; Group 4, 5 x  106 
RAMB B10 bone marrow cells +  15 X 108 RAMB B10.D2; Group 5, 2.5 x  108 
L3T4+-depleted B10 +  2.5 x  108 Lyt-2÷-depleted B10 bone marrow cells +  15 
x  106  RAMB B10.D2.  As  seen  in  Table  I,  the  pattern  of lymphopoietic  re- 
population of the recipients depended upon the protocols used for syngeneic T 
cell  subset depletion.  Those  mixed,  allogeneically  reconstituted  mice  that  re- 
ceived syngeneic bone marrow from which the Lyt-2÷-bearing cells had not been 
eliminated repopulated exclusively with syngeneic (B10) cells as shown by FMF 
(Table  I;  groups  2  and  5).  In  contrast,  all  groups  in  which  the  Lyt-2  + T  cell 
phenotypes  had  been  depleted  repopulated  as  mixed  lymphopoietic  chimeras 
with variable percentages of B10 and B10.D2 cells (Table I; groups 1, 3, and 4), 
although  some  individual  animals  had  very low levels of chimerism  detected. 
However, the  low  number  of B10.D2  cells  in  such  animals  was nevertheless 
distinctly  detectable as a  peak  separated  from  the  background  on  cell  sorter 
profiles (data not shown).  These data indicate  that  elimination  of Lyt-2  + cells 
from the syngeneic component of the mixed allogeneic bone marrow inoculum 
is necessary to permit engraftment of allogeneic donor bone marrow cells. 
Effect of T Cell Subset Depletions from Syngeneic Component of Bone Marrow in 
Mixed AUogeneic Reconstitution on Specific Acceptance of Donor Skin Allografts.  To 
assess the effect of selective depletions of various T cell subsets from the syngeneic 
component  of the  mixed  marrow  inoculum  on  the  ability  to  induce  specific 
transplantation  tolerance  to  an  allogeneic  donor,  animals  from  each  of  the 
treatment groups were grafted with B 10.D2 (donor-type) and third-party B 10.BR 
full-thickness tail skin grafts 6 wk after bone marrow transplantation.  Those mice 
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TABLE  I 
Effect of Depletion of Lyt-2 +, L3T4 +, and Thy-I + Cell Subsets from Syngeneic Component of 
Bone Marrow lnocula on EngraJ~ment of  Allogeneic Donor 
Group 
Syngeneic (B10) bone marrow T cell  Number 
depletions  for reconstitution  of mice 
Typing of chimeras by FMF 
Mean percent  Mean percent 
B 10 cells*  B 10.D2 cells* 
(range)  (range) 
1  Lyt-2  + cells  8  88.8  14.4 
(74.8-99.2)  (1.09-33.1) 
2  L3T4  + cells  7  97.16  1.63 
(95.7-98.4)  (0.24-3.43) 
3  Thy- 1  + cells  5  74.14  31.14 
(52.4-93.3)  (13.87-52.5) 
4  RAMB  + cells  4  78.25  23.76 
(50.68-98.53)  (0.9-51.93) 
5  "Addback" of L3T4 + plus Lyt-2  + cells  5  96.74  1.24 
(95.1-98.3)  (0.4-2.7) 
Normal B I 0 PBL  --  98.4  1.3 
Normal BI0.D2 PBL  --  3.71  95.5 
* Percent of cells with fluorescence  intensity  >250 on log scale after staining with anti-H-2 b or anti-H-2 d Protein 
A-purified biotinylated  mAb minus percent staining with FITC-Avidin alone on that respective animal. Correction 
was not made for low level of crossreactivity on normal B10 or normal B10.D2 peripheral blood lymphoid cells. 
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FIGURE  1.  Survival ofB 10.D2 and third-party B 10.BR full-thickness tail skin allografts placed 
on the lateral thoracic wall of mixed allogeneically reconstituted mice (B 10 +  B 10.D2 ~  B 10). 
B10  recipients were reconstituted with mixed marrow inocula of 15  x  106  RAMB  B10.D2 
bone marrow cells plus syngeneic bone marrow depleted of various T  cell subsets, as indicated 
in the figure. Skin grafts were followed for a minimum of 45 d. 
RAMB+-depleted, or Thy-l÷-depleted groups) exhibited specific acceptance of 
B10.D2  allogeneic donor  skin  grafts  (Fig.  1).  In  contrast,  those animals  that 
received either mixed marrow from which only L3T4-reactive cells had been 
depleted  from  the  syngeneic component  of the  inoculum,  or  an  "addback" 
mixture of L3T4-depleted plus Lyt-2-depleted syngeneic bone marrow, rejected 
B10.D2  grafts  with a  time course similar to  that  for rejection of third-party 
B10.BR skin grafts. 
Effect of Selective  Syngeneic  T  Cell Subset Depletions on MLR and CML Reactiv- 
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TABLE II 
Mixed Lymphocyte Reactivity (MLR) in Mixed Allogeneic Reconstitution: The Effect of Selective 
Depletion of Syngeneic T cell Subsets on Reactivity to AUogeneic Donor 
Responder 
Counts per minute ±  SEM* ([SH]thymidine 
incorporation) 
Syngeneic bone marrow T  cell 
Group~  depletions for mixed reconstitution  Anti-Bl0  Anti-B10.D2  Anti-B10.BR 
(B10 +  B10.D2 ~B10) 
1  Lyt-2  ÷ cells  8,631  -+ 1,033  7,294 --. 636  55,814 +  3,009 
2  L3T4  ÷ cells  8,235 -I- 568  36,911  ±  3,400  63,725 +  4,208 
3  Thy-1 ÷ cells  8,736 +  298  6,904 ±  1,487  24,920 +  724 
4  RAMB  ÷ cells  5,830 ±  966  8,644 ±  385  12,024 ±  415 
5  "Addback" of L3T4 ÷ and Lyt-2  ÷ cells  7,903 ±  1,154  21,550 ±  2,925  27,885 ±  2,763 
Normal B10  7,946 ±  341  35,658 ±  373  40,786 -+ 887 
Normal B10.D2  29,373 ±  1,229  7,201  +  267  36,665 +  965 
* Mean --. SEM of triplicate cultures at 1 : 1 responder/stimulator ratio. 
* The animals represented above have typing data presented in Table I and are as follows: Group I (No. 6: 93.3% 
B10, 6.5% BI0.D2); Group 2 (No. 4: 97.1% B10,  1.7% BI0.D2); Group 4 (No. 2: 50.7% BI0, 51.9% B10.D2); 
Group 5 (No. 2: 95.9% B10, 2.7% B10.D2). 
immunocompetence to respond to third-party lymphoid elements, splenic lymph- 
oid  cells  from  animals  reconstituted  according  to  each  of the  five  treatment 
protocol groups were tested in MLR assays. Table II illustrates the responses of 
individual  animals  in  one  representative  experiment.  Recipients  reconstituted 
with mixed bone marrow inocula from which the Lyt-2  ÷ syngeneic T  cells had 
been  depleted  before  transplantation  (Table  II,  groups  1,  3,  and  4)  showed 
specific absence of reactivity to syngeneic (B 10) and allogeneic (B 10.D2) donor 
strains,  yet were competent  to  respond  to  third  party  (B10.BR).  In  contrast, 
those animals that received mixed bone marrow inocula from which the Lyt-2- 
reactive cells had  not been  depleted were fully reactive to  B10.D2  ailogeneic 
donor,  with  a  response similar  in  magnitude  to  that  for third  party (B10.BR) 
(Table II,  groups 2  and 5).  These responses were observed consistently within 
groups irrespective of the degree of chimerism  detected in individual  animals. 
Similar results were obtained in an in vitro, cell-mediated lympholysis sensitiza- 
tion.  Only lymphoid cells from  mice that  had  received Lyt-2÷-depleted mixed 
bone  marrow  inocula  were  unreactive  to  the  B10.D2  allogeneic  donor,  yet 
reactive to third party. 
Discussion 
Alloresistance  to  engraftment  of  bone  marrow  has  posed  a  longstanding 
challenge to the field of clinical transplantation.  Murine, rat, and porcine models 
for this phenomenon have implicated both NK cells and cytotoxic T  cells (6-8). 
However, the definitive cell phenotype has not been shown convincingly. To the 
extent that our model of mixed reconstitution simulates the general problem of 
resistance to bone marrow engraftment,  our results appear to provide a  means 
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cell in bone marrow  is responsible for the failure of long-term engraftment  of 
ailogeneic donor lymphoid elements observed in mixed allogeneic reconstitution 
when  the  syngeneic  component  of the  mixed  bone  marrow  inoculum  is  not 
depleted of RAMB-reactive cells. These Lyt-2  ÷ T  cells are perhaps cytotoxic T 
cells  or  their  precursors.  In  general,  Lyt-2  ÷ cells  react  with  class  I  antigens, 
whereas L3T4 + cells react with class II antigens.  Therefore, the relevant target 
cell populations are likely to express class I but not class II antigens. 
The level of engraftment  at 6  wk posttransplantation  varied from animal  to 
animal.  Some mice treated  with either  RAMB, anti-Thy-1,  or anti-Lyt-2.2  re- 
populated with as little as 1% allogeneic cells. However, even this small percent- 
age of cells was sufficient to induce tolerance in these mice, as determined by 
skin graft acceptance. Since we have not examined the short-term  engraftment 
of these animals,  it remains  possible that  mice reconstituted  with  marrow  not 
depleted of Lyt-2 may engraft for a  short time.  However, the allogeneic bone 
marrow  population  must  then  be  eliminated  by the  mature  Lyt-2  ÷ syngeneic 
cells, since by 8 wk no evidence for allogeneic engraftment could be seen. 
In  our  previous  studies  using  RAMB  for  T  cell  depletions,  we  could  not 
determine  whether  NK  cells  or  T  cells  were  responsible  for  the  failure  of 
engraftment of allogeneic donor bone marrow, because NK cells in culture have 
been reported to be crossreactive with RAMB (9-13).  Since native NK cells do 
not express Lyt-2 (13, 14), the present data strongly suggest that the alloresistance 
to engraftment  observed in  mixed allogeneic reconstitution  is  mediated by an 
Lyt-2  + T  cell and not by NK cells. 
This model of mixed allogeneic reconstitution should allow further discrimi- 
nation of the characteristics of the syngeneic T  cell component responsible for 
alioresistance.  To the extent  that  a  similar cell  type mediates alloresistance  in 
general,  identification  of such a  cell  phenotype  may allow better  targeting  of 
treatment with specific mAbs rather than the aggressive, less specific approaches 
that are required for conditioning of bone marrow transplant  recipients at this 
time. 
Summary 
In the mixed allogeneic reconstitution (B10 +  B10.D2 --~ B10) model, allore- 
sistance to engraftment of allogeneic donor results if the syngeneic component 
of the  mixed  bone  marrow  inoculum  is  not  depleted  of Lyt-2  ÷ cells  before 
transplantation.  Resultant  experimental  animals  repopulate  as fully syngeneic, 
reject B 10.D2 skin allografts, and are reactive to B 10.D2 lymphoid cells in vitro, 
as assessed by mixed lymphocyte culture proliferative and cellular  cytotoxicity 
assays. In contrast,  depletion of Lyt-2-reactive cells from the syngeneic compo- 
nent  of  the  mixed  bone  marrow  inoculum  results  in  mixed  lymphopoietic 
chimerism  and  specific in  vivo transplantation  tolerance  to B10.D2  allogeneic 
donor skin grafts and  in vitro unreactivity to B10.D2  lymphoid elements.  Full 
reactivity to third party is evident both in vitro and in vivo in these animals. This 
model may be helpful in further study of the syngeneic host-type cell phenotypes 
responsible for alloresistance to bone marrow engraftment. 
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